Vascular medicine and cardio-oncology – A new, evolving clinical frontier-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vascular medicine and cardio-oncology – A new, evolving clinical frontier

Published:2020-06 Issue:3 Volume:25 Page:205-207
ISSN:1358-863X
Container-title:Vascular Medicine
language:en
Short-container-title:Vasc Med

Author:

Versmissen Jorie¹^ORCID,Power John R²³⁴,Moslehi Javid²³⁴

Affiliation:

1. Departments of Internal Medicine and Hospital Pharmacy, Erasmus MC University Medical Center, Rotterdam, The Netherlands

2. Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA

3. Division of Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA

4. Division Cardio-Oncology Program, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1358863X20910786

Reference20 articles.

1. Cancer treatment and survivorship statistics, 2016

2. Cardiovascular Toxic Effects of Targeted Cancer Therapies

3. Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association

4. Vascular effects of cancer treatments

5. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of tumor characteristics on cardiovascular disease death in breast cancer patients with CT or RT: a population-based study;Frontiers in Cardiovascular Medicine;2023-05-09

2. Prognostic Value of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging for Predicting Venous Thromboembolism in Children With Lymphoma;Circulation: Cardiovascular Imaging;2023-04

3. Cardiovascular toxicity of angiogenesis inhibitors and immune checkpoint inhibitors: synergistic anti-tumour effects at the cost of increased cardiovascular risk?;Clinical Science;2021-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3